Loading...
Please wait while we get things ready for you
Please wait while we get things ready for you
Supergirl opened to just $18 million on Friday — landing in second place behind Disney and Pixar's Toy Story 5, which pulled in $21 million from 4,425 screens — and is tracking toward a $40-50 million weekend. That's a steep comedown from last summer, when James Gunn's Superman debuted to $125 million on its way to $618 million worldwide. The $170 million DC gambit arrives saddled with a 57% Rotten Tomatoes critics score. Audiences have...
PCE Hits 4.1%: Inflation hit a three-year high, flipping Wall Street's narrative from "when will the Fed cut?" to "how soon will it hike?" Minneapolis Fed President Neel Kashkari confirmed he's penciled in one increase for 2026, and JPMorgan's Bruce Kasman warned the market is underestimating how sticky price pressures remain. The Kevin Warsh-led Fed is a "black box" on timing, leaving traders guessing.
Grantham Calls AI Bubble Peak: Legendary investor Jeremy Grantham told The...
China's National Medical Products Administration approved CARsgen Therapeutics' satri-cel for stomach cancer on June 22 — the first time any regulator has greenlit a CAR T-cell therapy for a solid tumor. CAR T has revolutionized blood cancers over the past decade, but solid tumors have resisted every attempt. This approval changes the equation.
The Dow survived the week, and that counts. It rallied more than 1% to settle just below 52,000, eking out a weekly gain while the S&P 500 and Nasdaq stumbled — old-economy names became a feature, not a bug, as money fled tech for healthcare and consumer staples. JPMorgan raised its S&P 500 year-end target to 7,800 from 7,600, admitting it had been "much too cautious" on earnings and now forecasting $350 per share in 2026 EPS — 29% growth. The S&P 500 is...
The AI industry's two biggest names are betting on radically different capital strategies — and one of them is wrong. OpenAI is playing hardball on its $1 trillion valuation by delaying its IPO to 2027 rather than accept a lower number. Meanwhile, Chinese rival DeepSeek has abandoned its techno-idealist "no funding, no commercialization" stance entirely to raise a record $7 billion and sprint toward AGI at full throttle. The winner of this bet will shape how AI...
The CDC just pulled the biggest lever in its emergency toolkit. On Friday, the agency raised its Ebola response to Level 1 — the highest internal alert — as the outbreak ravaging the Democratic Republic of Congo and Uganda shows no signs of slowing. More than 1,100 people have tested positive since May, and at least 250 have died, though officials concede the real number is likely far higher since the virus spread undetected for months. "We are very concerned about the...
Move over, biohackers. The wellness icon of the moment is someone's Italian grandmother. "Nonnamaxxing" — the trend of adopting the daily rhythms of a nonna — is trending hard, and it comes with serious longevity street cred. Think cooking from scratch, tending herbs, taking slow "passeggiata" walks, sharing long meals, and limiting screen time. Linguist Noël Wolf of Babbel calls it "a universal archetype — the older woman who lives simply, cooks well, stays...
The "Hot Rate-Cut Summer" is officially dead. May's Personal Consumption Expenditures index — the Fed's preferred inflation gauge — hit 4.1%, the highest annual reading in over three years, with core PCE holding at 3.4%. Economists have stopped asking when the Fed will cut and started asking how soon it will hike. Markets broadly expect the Fed to hold steady at the July 16-17 meeting, but September is very much in play for a rate increase, according to pricing in...
NAIC confirms Oracle zero-day breach — ShinyHunters claims 3.1TB of data stolen from the insurance regulatory body after attackers exploited an unpatched Oracle PeopleSoft vulnerability. The group began exploiting the zero-day on May 27 and compromised over 100 organizations before Oracle patched June 10. Stolen data includes insurer filings, credit ratings, AWS logs, and configs. NAIC says no ransom was paid.
**Polymarket loses $3M in supply-chain...
OpenAI has launched a limited preview of its next-generation GPT-5.6 model series—Sol, Terra, and Luna—to select partners. This rollout follows an executive order from President Donald J. Trump, which mandates a 30-day process for benchmarking and assessing new AI models for safety before wider release.
Meanwhile, the tech industry faces several challenges and shifts. A deepening tech slump is observed, driven by concerns over the sustainability of the AI trade, rising semiconductor costs, and...
The US government has partially reversed its two-week-old ban on Anthropic's Claude Mythos 5, allowing over 100 "trusted" US organizations — including Fortune 500 companies — access to the powerful AI model that the NSA previously confirmed "broke into almost all of our classified systems... in hours." The partial lift comes after Washington abruptly barred Anthropic from giving foreign nationals access to Mythos 5 and its sibling Fable 5 on June 12 over fears the models'...
The FDA has approved Viridian Therapeutics' veligrotug, branded as Lumvoa, for thyroid eye disease — ending Amgen's Tepezza's solo run as the only approved therapy since 2020. Thyroid eye disease, an autoimmune condition causing painful eye bulging, double vision, and potential vision loss, has been a one-drug monopoly. CEO Steve Mahoney said Lumvoa will be priced "in line with" Tepezza, setting up a direct head-to-head pricing battle from day one. For...